Efficacy and safety of using Elexacaftor/Tezacaftor/Ivacaftor in the treatment of children with cystic fibrosis: real-world evidence from Brazil Guilherme da Silva Martins, Carolina Rambo, Gabriela Spessatto, Maitê Milagres Saab, Bruno Hernandes David João, Aline Didoni Fajardo, Juliana Gonçalves Primon, Thalita Gonçalves Picciani, Roberta Corrêa da Cunha, Herberto José Chong-Neto, Carlos Roberto Lebarbenchon Massignan, Luiz Vicente Ribeiro Ferreira da Silva-Filho, Carlos Antônio Riedi, Nelson Augusto Rosário Filho, Débora Carla Chong-Silva

The Impact of Cystic Fibrosis on the Immunologic Profile of Pediatric Patients Daniela M. Bernardi, Antonio F. Ribeiro, Tais N. Mazzola, Maria M.S. Vilela, Valdemiro C. Sgarbieri

Hepatobiliary disease in children and adolescents with cystic fibrosis Fernanda de S. Nascimento, Nelson A. Sena, Tatiane da A. Ferreira, Cibele D.F. Marques, Luciana R. Silva, Edna Lúcia Souza